"Jurkat Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation.
| Descriptor ID |
D019169
|
| MeSH Number(s) |
A11.251.210.190.495 A11.251.860.180.495 A15.382.490.555.567.569.440
|
| Concept/Terms |
Jurkat Cells- Jurkat Cells
- Cell, Jurkat
- Cells, Jurkat
- Jurkat Cell
|
Below are MeSH descriptors whose meaning is more general than "Jurkat Cells".
Below are MeSH descriptors whose meaning is more specific than "Jurkat Cells".
This graph shows the total number of publications written about "Jurkat Cells" by people in this website by year, and whether "Jurkat Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 19 | 20 |
| 2018 | 0 | 18 | 18 |
| 2019 | 0 | 5 | 5 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Jurkat Cells" by people in Profiles.
-
Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
-
Flow cytometry detection of sustained humoral immune response (IgG + IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection. Sci Rep. 2021 05 21; 11(1):10716.
-
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS Pathog. 2021 05; 17(5):e1009576.
-
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses. J Clin Invest. 2021 05 17; 131(10).
-
SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination. Cell Death Differ. 2021 09; 28(9):2765-2777.
-
Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein. EMBO Mol Med. 2021 03 05; 13(3):e13549.
-
Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides. Immunohorizons. 2021 02 04; 5(2):70-80.
-
Autophagy in T cells from aged donors is maintained by spermidine and correlates with function and vaccine responses. Elife. 2020 12 15; 9.
-
Primidone blocks RIPK1-driven cell death and inflammation. Cell Death Differ. 2021 05; 28(5):1610-1626.
-
Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease. Comput Biol Chem. 2020 Dec; 89:107376.